Saarvik Pharmaceuticals Private Limited

Saarvik Pharmaceuticals Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2019PTC348644 Incorporated 12 April 2019 ROC Delhi HQ Delhi, India
Active Private Limited Company trading MSME · Micro
Revenue · FY 2024
₹18.63 Lakh
▲ 38% YoY
Net loss · FY 2024
₹89,052
Net margin -4.8%
EBITDA · FY 2024
-₹85,501
EBITDA margin -4.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Saarvik Pharmaceuticals Private Limited

Data last updated:

Saarvik Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 12 April 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC348644. Its GSTIN is 09ABBCS9101R1ZS (Uttar Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arvind Kumar Sharma and Suman Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 354 – A Gali No. 16 Bhajanpura Shahdara, Delhi, India – 110053.

As per the financials filed for FY 2024, the company reported a revenue of ₹18.63 Lakh, a growth of 38% compared to the previous year. For the same year it recorded a net loss of ₹89,052 (net margin -4.8%) and EBITDA of -₹85,501 (EBITDA margin -4.6%).

Saarvik Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0026784).

Company details

CIN U51909DL2019PTC348644
Registration Number 348644
Incorporation Date 12 April 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0026784

Recognitions & Rankings of Saarvik Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UP-50-0026784

Contact details

Saarvik Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C – 354 – A Gali No. 16 Bhajanpura Shahdara, Delhi, India – 110053
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Saarvik Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Saarvik Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Saarvik Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Saarvik Pharmaceuticals Private Limited, buy the company report.

Financials of Saarvik Pharmaceuticals Private Limited

FY 2025 filings available

Saarvik Pharmaceuticals Private Limited reported revenue of ₹18.63 Lakh (up 38% YoY) for FY 2024.

Revenue · FY 2024
₹18.63 Lakh ▲ 38%
Net loss · FY 2024
₹89,052 margin -4.8%
EBITDA · FY 2024
-₹85,501 margin -4.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 38%
EBITDA CAGR growth
3 years · compounded
▼ 116%

Revenue rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹85,501
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹89,052
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-4.6%
Net Profit Margin-4.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Saarvik Pharmaceuticals Private Limited, buy the company report.

Board of directors of Saarvik Pharmaceuticals Private Limited

Saarvik Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arvind Kumar SharmaDirector12 Apr 20197 Years 7 MonthsCurrent
Suman SharmaDirector02 Dec 20214 Years 11 MonthsCurrent

Peer comparison

Saarvik Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Humakind Pharmaceuticals Private Limited₹18.78 Lakh (FY 2025)32.0%Basti, Uttar Pradesh, India
Els Pharmaceuticals Private Limited₹18.64 Lakh (FY 2025)65.0%Chennai, Tamil Nadu, India
Saarvik Pharmaceuticals Private Limitedthis company₹18.63 Lakh (FY 2024)-₹89,052-4.8%38.0%Delhi, India
Medworld Pharmaceuticals Private Limited₹18.56 Lakh (FY 2025)-74.0%Thane, Maharashtra, India

To see the full peer comparison of Saarvik Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Saarvik Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Saarvik Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09ABBCS9101R1ZSUttar PradeshActive12 Sep 2021

To see the full GST registrations and return filing status of Saarvik Pharmaceuticals Private Limited, buy the company report.

Recent activity

Saarvik Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Santosh Kumar Sharma ceased to be Director on 02 Dec 2021.

AGM
Saarvik Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Saarvik Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Santosh Kumar Sharma ceased to be Director.
Appointed
Suman Sharma was appointed as Director.
Appointed
Arvind Kumar Sharma was appointed as Director.
Incorporation
12 Apr 2019
Saarvik Pharmaceuticals Private Limited was registered on 12 Apr 2019 with Roc Delhi & aged 7 years 7 months as per MCA records.

Frequently asked questions

Saarvik Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 12 April 2019 (7+ years old) and is registered under CIN U51909DL2019PTC348644.

Saarvik Pharmaceuticals has 2 current directors:

The latest financial statements of Saarvik Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Saarvik Pharmaceuticals is 09ABBCS9101R1ZS, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Saarvik Pharmaceuticals is U51909DL2019PTC348644. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Saarvik Pharmaceuticals was incorporated on 12 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Saarvik Pharmaceuticals by revenue are Humakind Pharmaceuticals Private Limited, Els Pharmaceuticals Private Limited, Medworld Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).

Santosh Kumar Sharma ceased to be Director on 02 Dec 2021. Suman Sharma was appointed as Director on 02 Dec 2021. Arvind Kumar Sharma was appointed as Director on 12 Apr 2019.

Yes, Saarvik Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0026784).

The registered office of Saarvik Pharmaceuticals is at C – 354 – A Gali No. 16 Bhajanpura Shahdara, Delhi, India – 110053.

Saarvik Pharmaceuticals operates in the trading industry, in the specialty segment.